IRAK1BP1 and neoplasm: As a result, we decided to further investigate the expression of IRAK1BP1 in patient samples from TCGA as well as 3 independent cohorts; our findings suggested that IRAK1BP1 expression in LUAD patients resembled what was observed in the organoid models, showing reduced expression in tumor tissue relative to normal tissue (Figure 1F).